Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998
Multiple Sclerosis Associated with Chlamydia Pneumoniae Infection of the CNS
Neurol 50:571-572, Sriram,S.,et al, 1998
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998
Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998
Transverse Myelitis, Comparison with Spinal Cord Presentations of Multiple Sclerosis
Neurol 50:429-433, Scott,T.F.,et al, 1998
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998
Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998
Epilepsy in Patients with Multiple Sclerosis: Radiological-Clinical Correlations
Epilepsia 39:893-896, Moreau,Th.,et al, 1998
Physiologic MRI of a Tumefactive Multiple Sclerosis Lesion
Neurol 51:1487-1488, Ernst,T.,et al, 1998
Women's Health Issues, Part 1
Med Clin North Am 82:77-101, Belilos,E. & Carsons,S., 1998
Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997
Multiple Sclerosis Lesion Detection in the Brain:A Comparison of FLAIR & Conventional T2-Weighted Dual Spin Echo
Neurol 49:364-370, Gawne-Cain,M.L.,et al, 1997
Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997
Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997
Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997
Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997
Tizanidine for Spasticity
The Medical Letter 39:62, , 1997
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997
The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997
Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997
Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997
Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997
Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997
Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997
Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997
Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997
Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997
Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997
Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997
HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997
Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997
Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997
Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997
Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997